The global NK Cell Therapy market is projected to grow from US$ 408.9 million in 2024 to US$ 1006.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 16.2% during the forecast period.

NK Cell Therapy Market

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

Market Analysis and Insights: Global NK Cell Therapy Market

North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.The key manufacturers are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech etc. Top 3 companies occupied about 82% market share.

Report Covers:

This report presents an overview of global market for NK Cell Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of NK Cell Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for NK Cell Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the NK Cell Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global NK Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for NK Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of NK Cell Therapy Market Report

Report Metric	Details
Report Name	NK Cell Therapy Market
Accounted market size in 2024	US$ 408.9 million
Forecasted market size in 2030	US$ 1006.7 million
CAGR	16.2
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	NK Cell Therapies NK Cell Directed Antibodies
Segment by Application	Cancer Gastrointestinal Diseases Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of NK Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NK Cell Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NK Cell Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is NK Cell Therapy Market growing?

Ans: The NK Cell Therapy Market witnessing a CAGR of 16.2 during the forecast period 2024-2030.

What is the NK Cell Therapy Market size in 2030?

Ans: The NK Cell Therapy Market size in 2030 will be US$ 1006.7 million.

What is the NK Cell Therapy Market share by region?

Ans: North America is the largest NK Cell Therapy market with about 51% market share. Europe is follower, accounting for about 33% market share.

What is the market share of major companies in NK Cell Therapy Market?

Ans: Top 3 companies occupied about 82% market share.

Who are the main players in the NK Cell Therapy Market report?

Ans: The main players in the NK Cell Therapy Market are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics, Fortress Biotech

What are the Application segmentation covered in the NK Cell Therapy Market report?

Ans: The Applications covered in the NK Cell Therapy Market report are Cancer, Gastrointestinal Diseases, Others

What are the Type segmentation covered in the NK Cell Therapy Market report?

Ans: The Types covered in the NK Cell Therapy Market report are NK Cell Therapies, NK Cell Directed Antibodies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NK Cell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 NK Cell Therapies

1.2.3 NK Cell Directed Antibodies

1.3 Market by Application

1.3.1 Global NK Cell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Cancer

1.3.3 Gastrointestinal Diseases

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global NK Cell Therapy Market Perspective (2019-2030)

2.2 Global NK Cell Therapy Growth Trends by Region

2.2.1 NK Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 NK Cell Therapy Historic Market Size by Region (2019-2024)

2.2.3 NK Cell Therapy Forecasted Market Size by Region (2025-2030)

2.3 NK Cell Therapy Market Dynamics

2.3.1 NK Cell Therapy Industry Trends

2.3.2 NK Cell Therapy Market Drivers

2.3.3 NK Cell Therapy Market Challenges

2.3.4 NK Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue NK Cell Therapy by Players

3.1.1 Global NK Cell Therapy Revenue by Players (2019-2024)

3.1.2 Global NK Cell Therapy Revenue Market Share by Players (2019-2024)

3.2 Global NK Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of NK Cell Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global NK Cell Therapy Market Concentration Ratio

3.4.1 Global NK Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NK Cell Therapy Revenue in 2023

3.5 Global Key Players of NK Cell Therapy Head office and Area Served

3.6 Global Key Players of NK Cell Therapy, Product and Application

3.7 Global Key Players of NK Cell Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 NK Cell Therapy Breakdown Data by Type

4.1 Global NK Cell Therapy Historic Market Size by Type (2019-2024)

4.2 Global NK Cell Therapy Forecasted Market Size by Type (2025-2030)

5 NK Cell Therapy Breakdown Data by Application

5.1 Global NK Cell Therapy Historic Market Size by Application (2019-2024)

5.2 Global NK Cell Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America NK Cell Therapy Market Size (2019-2030)

6.2 North America NK Cell Therapy Market Size by Type

6.2.1 North America NK Cell Therapy Market Size by Type (2019-2024)

6.2.2 North America NK Cell Therapy Market Size by Type (2025-2030)

6.2.3 North America NK Cell Therapy Market Share by Type (2019-2030)

6.3 North America NK Cell Therapy Market Size by Application

6.3.1 North America NK Cell Therapy Market Size by Application (2019-2024)

6.3.2 North America NK Cell Therapy Market Size by Application (2025-2030)

6.3.3 North America NK Cell Therapy Market Share by Application (2019-2030)

6.4 North America NK Cell Therapy Market Size by Country

6.4.1 North America NK Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America NK Cell Therapy Market Size by Country (2019-2024)

6.4.3 North America NK Cell Therapy Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe NK Cell Therapy Market Size (2019-2030)

7.2 Europe NK Cell Therapy Market Size by Type

7.2.1 Europe NK Cell Therapy Market Size by Type (2019-2024)

7.2.2 Europe NK Cell Therapy Market Size by Type (2025-2030)

7.2.3 Europe NK Cell Therapy Market Share by Type (2019-2030)

7.3 Europe NK Cell Therapy Market Size by Application

7.3.1 Europe NK Cell Therapy Market Size by Application (2019-2024)

7.3.2 Europe NK Cell Therapy Market Size by Application (2025-2030)

7.3.3 Europe NK Cell Therapy Market Share by Application (2019-2030)

7.4 Europe NK Cell Therapy Market Size by Country

7.4.1 Europe NK Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe NK Cell Therapy Market Size by Country (2019-2024)

7.4.3 Europe NK Cell Therapy Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China NK Cell Therapy Market Size (2019-2030)

8.2 China NK Cell Therapy Market Size by Type

8.2.1 China NK Cell Therapy Market Size by Type (2019-2024)

8.2.2 China NK Cell Therapy Market Size by Type (2025-2030)

8.2.3 China NK Cell Therapy Market Share by Type (2019-2030)

8.3 China NK Cell Therapy Market Size by Application

8.3.1 China NK Cell Therapy Market Size by Application (2019-2024)

8.3.2 China NK Cell Therapy Market Size by Application (2025-2030)

8.3.3 China NK Cell Therapy Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia NK Cell Therapy Market Size (2019-2030)

9.2 Asia NK Cell Therapy Market Size by Type

9.2.1 Asia NK Cell Therapy Market Size by Type (2019-2024)

9.2.2 Asia NK Cell Therapy Market Size by Type (2025-2030)

9.2.3 Asia NK Cell Therapy Market Share by Type (2019-2030)

9.3 Asia NK Cell Therapy Market Size by Application

9.3.1 Asia NK Cell Therapy Market Size by Application (2019-2024)

9.3.2 Asia NK Cell Therapy Market Size by Application (2025-2030)

9.3.3 Asia NK Cell Therapy Market Share by Application (2019-2030)

9.4 Asia NK Cell Therapy Market Size by Region

9.4.1 Asia NK Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia NK Cell Therapy Market Size by Region (2019-2024)

9.4.3 Asia NK Cell Therapy Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America NK Cell Therapy Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America NK Cell Therapy Market Size by Type

10.2.1 Middle East, Africa, and Latin America NK Cell Therapy Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America NK Cell Therapy Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America NK Cell Therapy Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America NK Cell Therapy Market Size by Application

10.3.1 Middle East, Africa, and Latin America NK Cell Therapy Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America NK Cell Therapy Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America NK Cell Therapy Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America NK Cell Therapy Market Size by Country

10.4.1 Middle East, Africa, and Latin America NK Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America NK Cell Therapy Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America NK Cell Therapy Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Nektar Therapeutics

11.1.1 Nektar Therapeutics Company Details

11.1.2 Nektar Therapeutics Business Overview

11.1.3 Nektar Therapeutics NK Cell Therapy Introduction

11.1.4 Nektar Therapeutics Revenue in NK Cell Therapy Business (2019-2024)

11.1.5 Nektar Therapeutics Recent Developments

11.2 Innate Pharma SA

11.2.1 Innate Pharma SA Company Details

11.2.2 Innate Pharma SA Business Overview

11.2.3 Innate Pharma SA NK Cell Therapy Introduction

11.2.4 Innate Pharma SA Revenue in NK Cell Therapy Business (2019-2024)

11.2.5 Innate Pharma SA Recent Developments

11.3 Affimed

11.3.1 Affimed Company Details

11.3.2 Affimed Business Overview

11.3.3 Affimed NK Cell Therapy Introduction

11.3.4 Affimed Revenue in NK Cell Therapy Business (2019-2024)

11.3.5 Affimed Recent Developments

11.4 Chipscreen Biosciences

11.4.1 Chipscreen Biosciences Company Details

11.4.2 Chipscreen Biosciences Business Overview

11.4.3 Chipscreen Biosciences NK Cell Therapy Introduction

11.4.4 Chipscreen Biosciences Revenue in NK Cell Therapy Business (2019-2024)

11.4.5 Chipscreen Biosciences Recent Developments

11.5 Fate Therapeutics

11.5.1 Fate Therapeutics Company Details

11.5.2 Fate Therapeutics Business Overview

11.5.3 Fate Therapeutics NK Cell Therapy Introduction

11.5.4 Fate Therapeutics Revenue in NK Cell Therapy Business (2019-2024)

11.5.5 Fate Therapeutics Recent Developments

11.6 Glycostem Therapeutics

11.6.1 Glycostem Therapeutics Company Details

11.6.2 Glycostem Therapeutics Business Overview

11.6.3 Glycostem Therapeutics NK Cell Therapy Introduction

11.6.4 Glycostem Therapeutics Revenue in NK Cell Therapy Business (2019-2024)

11.6.5 Glycostem Therapeutics Recent Developments

11.7 Dragonfly Therapeutics

11.7.1 Dragonfly Therapeutics Company Details

11.7.2 Dragonfly Therapeutics Business Overview

11.7.3 Dragonfly Therapeutics NK Cell Therapy Introduction

11.7.4 Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2019-2024)

11.7.5 Dragonfly Therapeutics Recent Developments

11.8 Kiadis Pharma

11.8.1 Kiadis Pharma Company Details

11.8.2 Kiadis Pharma Business Overview

11.8.3 Kiadis Pharma NK Cell Therapy Introduction

11.8.4 Kiadis Pharma Revenue in NK Cell Therapy Business (2019-2024)

11.8.5 Kiadis Pharma Recent Developments

11.9 NantWorks

11.9.1 NantWorks Company Details

11.9.2 NantWorks Business Overview

11.9.3 NantWorks NK Cell Therapy Introduction

11.9.4 NantWorks Revenue in NK Cell Therapy Business (2019-2024)

11.9.5 NantWorks Recent Developments

11.10 Nkarta Therapeutics

11.10.1 Nkarta Therapeutics Company Details

11.10.2 Nkarta Therapeutics Business Overview

11.10.3 Nkarta Therapeutics NK Cell Therapy Introduction

11.10.4 Nkarta Therapeutics Revenue in NK Cell Therapy Business (2019-2024)

11.10.5 Nkarta Therapeutics Recent Developments

11.11 Fortress Biotech

11.11.1 Fortress Biotech Company Details

11.11.2 Fortress Biotech Business Overview

11.11.3 Fortress Biotech NK Cell Therapy Introduction

11.11.4 Fortress Biotech Revenue in NK Cell Therapy Business (2019-2024)

11.11.5 Fortress Biotech Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Nektar Therapeutics

Innate Pharma SA

Chipscreen Biosciences

Fate Therapeutics

Glycostem Therapeutics

Dragonfly Therapeutics

List of Tables

Table 1. Global NK Cell Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of NK Cell Therapies

Table 3. Key Players of NK Cell Directed Antibodies

Table 4. Global NK Cell Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global NK Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global NK Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global NK Cell Therapy Market Share by Region (2019-2024)

Table 8. Global NK Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global NK Cell Therapy Market Share by Region (2025-2030)

Table 10. NK Cell Therapy Market Trends

Table 11. NK Cell Therapy Market Drivers

Table 12. NK Cell Therapy Market Challenges

Table 13. NK Cell Therapy Market Restraints

Table 14. Global NK Cell Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global NK Cell Therapy Revenue Share by Players (2019-2024)

Table 16. Global Top NK Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2023)

Table 17. Global NK Cell Therapy Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by NK Cell Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of NK Cell Therapy, Headquarters and Area Served

Table 20. Global Key Players of NK Cell Therapy, Product and Application

Table 21. Global Key Players of NK Cell Therapy, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global NK Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global NK Cell Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global NK Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global NK Cell Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global NK Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global NK Cell Therapy Revenue Share by Application (2019-2024)

Table 29. Global NK Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global NK Cell Therapy Revenue Share by Application (2025-2030)

Table 31. North America NK Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America NK Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America NK Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America NK Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America NK Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America NK Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America NK Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe NK Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe NK Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe NK Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe NK Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe NK Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe NK Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe NK Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 45. China NK Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 46. China NK Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 47. China NK Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 48. China NK Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia NK Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia NK Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia NK Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia NK Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia NK Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia NK Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia NK Cell Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America NK Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America NK Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America NK Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America NK Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America NK Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America NK Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America NK Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 63. Nektar Therapeutics Company Details

Table 64. Nektar Therapeutics Business Overview

Table 65. Nektar Therapeutics NK Cell Therapy Product

Table 66. Nektar Therapeutics Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 67. Nektar Therapeutics Recent Developments

Table 68. Innate Pharma SA Company Details

Table 69. Innate Pharma SA Business Overview

Table 70. Innate Pharma SA NK Cell Therapy Product

Table 71. Innate Pharma SA Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 72. Innate Pharma SA Recent Developments

Table 73. Affimed Company Details

Table 74. Affimed Business Overview

Table 75. Affimed NK Cell Therapy Product

Table 76. Affimed Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 77. Affimed Recent Developments

Table 78. Chipscreen Biosciences Company Details

Table 79. Chipscreen Biosciences Business Overview

Table 80. Chipscreen Biosciences NK Cell Therapy Product

Table 81. Chipscreen Biosciences Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 82. Chipscreen Biosciences Recent Developments

Table 83. Fate Therapeutics Company Details

Table 84. Fate Therapeutics Business Overview

Table 85. Fate Therapeutics NK Cell Therapy Product

Table 86. Fate Therapeutics Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 87. Fate Therapeutics Recent Developments

Table 88. Glycostem Therapeutics Company Details

Table 89. Glycostem Therapeutics Business Overview

Table 90. Glycostem Therapeutics NK Cell Therapy Product

Table 91. Glycostem Therapeutics Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 92. Glycostem Therapeutics Recent Developments

Table 93. Dragonfly Therapeutics Company Details

Table 94. Dragonfly Therapeutics Business Overview

Table 95. Dragonfly Therapeutics NK Cell Therapy Product

Table 96. Dragonfly Therapeutics Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 97. Dragonfly Therapeutics Recent Developments

Table 98. Kiadis Pharma Company Details

Table 99. Kiadis Pharma Business Overview

Table 100. Kiadis Pharma NK Cell Therapy Product

Table 101. Kiadis Pharma Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 102. Kiadis Pharma Recent Developments

Table 103. NantWorks Company Details

Table 104. NantWorks Business Overview

Table 105. NantWorks NK Cell Therapy Product

Table 106. NantWorks Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 107. NantWorks Recent Developments

Table 108. Nkarta Therapeutics Company Details

Table 109. Nkarta Therapeutics Business Overview

Table 110. Nkarta Therapeutics NK Cell Therapy Product

Table 111. Nkarta Therapeutics Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 112. Nkarta Therapeutics Recent Developments

Table 113. Fortress Biotech Company Details

Table 114. Fortress Biotech Business Overview

Table 115. Fortress Biotech NK Cell Therapy Product

Table 116. Fortress Biotech Revenue in NK Cell Therapy Business (2019-2024) & (US$ Million)

Table 117. Fortress Biotech Recent Developments

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Global NK Cell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global NK Cell Therapy Market Share by Type: 2023 VS 2030

Figure 3. NK Cell Therapies Features

Figure 4. NK Cell Directed Antibodies Features

Figure 5. Global NK Cell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global NK Cell Therapy Market Share by Application: 2023 VS 2030

Figure 7. Cancer Case Studies

Figure 8. Gastrointestinal Diseases Case Studies

Figure 9. Others Case Studies

Figure 10. NK Cell Therapy Report Years Considered

Figure 11. Global NK Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global NK Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global NK Cell Therapy Market Share by Region: 2023 VS 2030

Figure 14. Global NK Cell Therapy Market Share by Players in 2023

Figure 15. Global Top NK Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NK Cell Therapy as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by NK Cell Therapy Revenue in 2023

Figure 17. North America NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America NK Cell Therapy Market Share by Type (2019-2030)

Figure 19. North America NK Cell Therapy Market Share by Application (2019-2030)

Figure 20. North America NK Cell Therapy Market Share by Country (2019-2030)

Figure 21. United States NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe NK Cell Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe NK Cell Therapy Market Share by Type (2019-2030)

Figure 25. Europe NK Cell Therapy Market Share by Application (2019-2030)

Figure 26. Europe NK Cell Therapy Market Share by Country (2019-2030)

Figure 27. Germany NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China NK Cell Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China NK Cell Therapy Market Share by Type (2019-2030)

Figure 35. China NK Cell Therapy Market Share by Application (2019-2030)

Figure 36. Asia NK Cell Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia NK Cell Therapy Market Share by Type (2019-2030)

Figure 38. Asia NK Cell Therapy Market Share by Application (2019-2030)

Figure 39. Asia NK Cell Therapy Market Share by Region (2019-2030)

Figure 40. Japan NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America NK Cell Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America NK Cell Therapy Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America NK Cell Therapy Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America NK Cell Therapy Market Share by Country (2019-2030)

Figure 50. Brazil NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries NK Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Nektar Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 57. Innate Pharma SA Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 58. Affimed Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 59. Chipscreen Biosciences Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 60. Fate Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 61. Glycostem Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 62. Dragonfly Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 63. Kiadis Pharma Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 64. NantWorks Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 65. Nkarta Therapeutics Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 66. Fortress Biotech Revenue Growth Rate in NK Cell Therapy Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions